Phylogeographic analysis of dengue virus serotype 1 and cosmopolitan serotype 2 in Africa.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 26 01 2023
revised: 24 03 2023
accepted: 09 04 2023
medline: 9 6 2023
pubmed: 24 4 2023
entrez: 23 04 2023
Statut: ppublish

Résumé

The origin and spread of dengue virus (DENV) circulating in Africa remain poorly characterized, with African sequences representing <1% of global sequence data. Whole genome sequencing was performed on serum samples (n = 29) from an undifferentiated fever study in 2016 in the Democratic Republic of Congo (DRC), and from febrile travelers returning from Africa. The evolutionary history of the newly acquired African DENV-1 (n = 1) and cosmopolitan genotype DENV-2 (n = 18) genomes was reconstructed using a phylogeographic, time-scaled Bayesian analysis on a curated DENV panel including all known African sequences. A minimum of 10 and eight introductions could be identified into Africa for DENV-1 and cosmopolitan DENV-2, respectively, almost all originating from Asia. Three introductions were previously unknown. The currently circulating virus comprises mainly the recently introduced clades and one long-established African clade. Robust geographical clustering suggests limited spread of DENV after each introduction. Our data identified the DRC as the source of the 2018 Angolan DENV-2 epidemic, and similarly, the 2013 Angolan DENV-1 outbreak as the origin of our DRC study. Active genomic surveillance of DENV in Africa at the portals of entry might help early outbreak response and limit sero- and genotype spread and human disease burden.

Identifiants

pubmed: 37088357
pii: S1201-9712(23)00521-0
doi: 10.1016/j.ijid.2023.04.391
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-52

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no competing interests to declare.

Auteurs

Philippe Selhorst (P)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; The Outbreak Research Team, Institute of Tropical Medicine, Antwerp, Belgium. Electronic address: pselhorst@itg.be.

Sebastian Lequime (S)

Microbial Ecology Cluster, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands.

Gytis Dudas (G)

Institute of Biotechnology, Life Sciences Centre, Vilnius University, Vilnius, Lithuania.

Sam Proesmans (S)

Department of Internal Medicine, Infectious Diseases & Tropical Medicine, University of Antwerp, Antwerp, Belgium.

Pascal Lutumba (P)

National Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo; University of Kinshasa, Kinshasa, Democratic Republic of Congo.

Freddy Katshongo (F)

Higher Institute of Medical Techniques, Kinshasa, Democratic Republic of Congo.

Kadrie Ramadan (K)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Isabel Micalessi (I)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Steve Ahuka-Mundeke (S)

National Institute of Biomedical Research, Kinshasa, Democratic Republic of Congo; Biomedical Department, Kinshasa Teaching Hospital, School of Medicine, Kinshasa University, Kinshasa, Democratic Republic of Congo.

Veerle Vanlerberghe (V)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Marjan Van Esbroeck (M)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Kevin K Ariën (KK)

Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Departement Biomedische Wetenschappen, University of Antwerp, Antwerp, Belgium.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH